Skip to main content

Correction: Hydrogen sulfide-releasing cyclooxygenase inhibitor ATB-346 enhances motor function and reduces cortical lesion volume following traumatic brain injury in mice

The Original Article was published on 04 December 2014

Correction: Journal of Neuroinflammation 2014, 11:196 https://doi.org/10.1186/s12974-014-0196-1

In this article [1], the magnification of Fig. 7 (histological evaluation) in panel B (TBI group) and C (TBI + TBZ group) were switched. Specifically, magnification B1 becomes C1 and magnification C1 becomes B1.

The revised Fig. 7 is given in this correction.

Fig. 7
figure 7

Histological examination of brain sections after 24 h. Brain sections from TBI mice and TBZ-treated mice (B and C respectively, see densitometry analysis F) demonstrated brain tissue injury and inflammatory cell infiltration. Naproxen treatment did not attenuate completely the development of acute brain injury at one and six hours after TBI (D, see densitometry analysis F). On the contrary, ATB-346 treatment reduced the degree of brain injury and the inflammatory cells infiltration (E, see densitometry analysis F) Sham group is represented in panel A. A1-E1 represent 20X magnification. Figure is representative of at least three experiments performed on different experimental days. ###P < 0.001 versus TBI

Reference

  1. Campolo M, Esposito E, Ahmad A, Di Paola R, Paterniti I, Cordaro M, Bruschetta G, Wallace JL, Cuzzocrea S. Hydrogen sulfide-releasing cyclooxygenase inhibitor ATB-346 enhances motor function and reduces cortical lesion volume following traumatic brain injury in mice. J Neuroinflamm. 2014;11:196. https://doi.org/10.1186/s12974-014-0196-1.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Salvatore Cuzzocrea.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Campolo, M., Esposito, E., Ahmad, A. et al. Correction: Hydrogen sulfide-releasing cyclooxygenase inhibitor ATB-346 enhances motor function and reduces cortical lesion volume following traumatic brain injury in mice. J Neuroinflammation 21, 139 (2024). https://doi.org/10.1186/s12974-024-03131-6

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12974-024-03131-6